Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee hears first hearing on bill to require standardized consent and civil remedies for chemical‑abortion complications
Summary
At the Senate Health Committee’s first hearing on Senate Bill 309, a proponent urged standardized consent about chemical‑abortion risks and new enforcement authority for the attorney general, citing FDA REMS changes and insurance‑claims data; committee members pressed for peer‑reviewed evidence and clarification on recordkeeping and causation in litigation.
A proponent of Senate Bill 309 told the Senate Health Committee that the bill would require standardized consent and give the attorney general enforcement authority against chemical‑abortion providers if complications occur.
The presenter said SB 309 — described in testimony as the Abortion Pill Provider Liability Education (APPLE) Act — would direct the Department of Health to develop a clear consent form so women and their families are aware of the risks of mifepristone and misoprostol and of their right to pursue civil remedies if complications arise. "This bill is an opportunity for abortion providers to ensure their patients are properly informed and…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
